- Rankings
- WIPR Insights
Jurisdiction Reports
Refine Search
Jurisdiction reports
One of the aims of the new Civil Procedure Code is to ensure access for appropriates parties to simpler procedural means and forms, as well as to accelerate the case settlement procedure, including the compulsory enforcement stage. 1 April 2013
Jurisdiction reports
Some major changes to damage claims for patent infringement have been made under Taiwan’s newly amended Patent Act. 1 April 2013
Jurisdiction reports
Significant changes to both the Canadian Trade-marks Act and the Copyright Act may be coming in the near future. 1 April 2013
Jurisdiction reports
The modernisation efforts of the Brazilian Patent and Trademark Office (INPI) have been welcomed by the local IP community. In March 2013, Commissioner Jorge Avila announced further improvements. 1 April 2013
Jurisdiction reports
The European Patent Convention (EPC) gives an applicant the possibility of dividing a pending European application by filing one or more divisional applications, which can be divided further. 1 April 2013
Jurisdiction reports
France has implemented EU Directive 2011/62/UE June 8, 2011 relating to medicinal products for human use, by enacting an ordinance of December 19, 2012 and a Decree No. 2012-1562 of December 31, 2012. 1 April 2013
Jurisdiction reports
On February 6, 2013, the State Intellectual Property Office of China (SIPO) published a draft amendment to the Guidelines for Examination, soliciting public comments. 1 April 2013
Jurisdiction reports
This article does not intend to provide yet another comment on the issue of using community trademarks (CTMs) in one or more countries since the Onel decision has made it clear that use of a CTM is not dependent on national boundaries. 1 April 2013
Jurisdiction reports
Several interesting decisions in intellectual property law have been seen in India since the last report, making it difficult to select reportable cases. We have picked out two that are likely to have a big impact. 1 April 2013
Jurisdiction reports
In the case of Ho Tack Sien & Ors v Rotta Research Laboratorium SpA & Anor, the respondent manufactured a drug called Viartril-S (glucosamine sulphate) used in the treatment of osteoarthritis. 1 April 2013
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.